August 11, 2015
Helendale Dermatology & Medical Spa has been selected to provide KYBELLA™ (deoxycholic acid) injection, the first and only FDA-approved non-surgical treatment for reduction of submental fullness, a common yet under-treated aesthetic condition also known as "double chin." KYBELLA™ was approved in April by the U.S. Food and Drug Administration (FDA), and can now be purchased by physicians who have been trained on the safe use of KYBELLA™ and its approved indication.
"Many people are concerned that a double chin makes them look older and heavier than they actually are," said Elizabeth Arthur, M.D. and Board Certified Dermatologist at Helendale Dermatology & Medical Spa. "With KYBELLA™, for the first time, people have access to a non-surgical solution to address this long-standing but common aesthetic concern. "
Dr. Arthur has completed the training and is a KYBELLA™ Trained Physician Trainer. Only physicians who have participated in a training program will be able to purchase KYBELLA™ and treat patients. Helendale Dermatology & Medical Spa is the only medical practice between Buffalo and Syracuse and one of 150 practices in the United Stated that was selected to provide KYBELLA™.
About Submental Fullness
Submental fullness is a common yet undertreated condition that can detract from an otherwise balanced and harmonious facial appearance-- leading to an older and heavier look. Submental fullness can affect adults -- both women and men -- of all ages, weight and gender. Influenced by multiple factors including aging and genetics, submental fullness is often resistant to diet and exercise.
KYBELLA™ is the first and only approved injectable drug for contouring moderate to severe submental fullness, a condition that is commonly referred to as a double chin. KYBELLA™ is a formulation of deoxycholic acid, a naturally occurring molecule in the body that aids in the breakdown and absorption of dietary fat. When injected into subcutaneous fat, KYBELLA™ causes the destruction of fat cells. Once destroyed, those cells cannot store or accumulate fat. KYBELLA™ causes the destruction of fat cells, so once the aesthetic response is achieved, retreatment is not expected.
KYBELLA™ is administered by injections into the fat under the chin, tailored to the treatment goals of the patient and their physician. In clinical trials, many patients experienced visible results in two to four treatments, though up to six treatments may be administered. The average dose was 2-3 vials per treatment session (which equates to 4-6 mL). The most common adverse reactions were associated with the injection site and included swelling, bruising, and soreness. KYBELLA™ treatment resulted in high patient satisfaction during clinical trials.
About Helendale Dermatology and Medical Spa:
Helendale Dermatology & Medical Spa was founded in 2004 by board-certified dermatologist, Dr. Elizabeth Arthur, as a full-service dermatology practice that specializes in medical, cosmetic and surgical care of the skin. The on-site Medical Spa offers a wide variety of services aimed at enhancing patients' natural beauty through laser, esthetic and skincare treatments. The practice is located at 500 Helendale Rd, Suite 100 in Rochester, New York and currently employs 29 people.